RISS 학술연구정보서비스

검색

인기 검색어

    다국어 입력

    http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

    변환된 중국어를 복사하여 사용하시면 됩니다.

    예시)
    • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
    • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
    닫기
    KCI등재

    Public health strategies for hepatocellular carcinoma: from risk factors to prevention and control

    한글로보기

    https://www.riss.kr/link?id=A109953819

    • 0

      상세조회
    • 0

      다운로드
    서지정보 열기
    • 내보내기
    • 내책장담기
    • 공유하기
    • 오류접수

    부가정보

    다국어 초록 (Multilingual Abstract) kakao i 다국어 번역

    Hepatocellular carcinoma (HCC) remains a major global health burden, ranking as one of the leading causes of cancer-related deathsworldwide. This review synthesizes current evidence on HCC epidemiology, highlighting both modifiable and non-modifiable riskfactors, including chronic hepatitis B and C virus infections, metabolic dysfunction-associated steatotic liver disease (MASLD),excessive alcohol consumption, aflatoxin exposure, and genetic susceptibility. These diverse etiologies reflect not only biologicalmechanisms but also broader social and environmental determinants of health, emphasizing the need for integrated, populationlevelpreventive strategies. Effective strategies across all levels of prevention are reviewed. Primordial and primary preventionstrategies include public health policies, health education to raise awareness, universal hepatitis B vaccination, expanded access toantiviral therapies for hepatitis B virus (HBV) and hepatitis C virus (HCV), lifestyle interventions targeting obesity and alcohol use,and environmental controls to reduce aflatoxin exposure. Secondary prevention focuses on early detection through viral hepatitisscreening and routine HCC surveillance in high-risk populations. Tertiary prevention aims to reduce morbidity and mortality throughtimely treatment and multidisciplinary care. Despite the availability of effective tools, substantial implementation gaps remainpersist. Underdiagnosis of viral hepatitis, low treatment uptake, inadequate surveillance coverage, and disparities in healthcareaccess continue to limit progress. Addressing these challenges requires a coordinated public health response grounded in healthsystem strengthening, policy innovation, and equitable access to care. A renewed public health commitment -integrating prevention,early diagnosis, and continuity of care- is essential to reduce the global burden of HCC and bridge the gap between knowledge andaction.
    번역하기

    Hepatocellular carcinoma (HCC) remains a major global health burden, ranking as one of the leading causes of cancer-related deathsworldwide. This review synthesizes current evidence on HCC epidemiology, highlighting both modifiable and non-modifiable ...

    Hepatocellular carcinoma (HCC) remains a major global health burden, ranking as one of the leading causes of cancer-related deathsworldwide. This review synthesizes current evidence on HCC epidemiology, highlighting both modifiable and non-modifiable riskfactors, including chronic hepatitis B and C virus infections, metabolic dysfunction-associated steatotic liver disease (MASLD),excessive alcohol consumption, aflatoxin exposure, and genetic susceptibility. These diverse etiologies reflect not only biologicalmechanisms but also broader social and environmental determinants of health, emphasizing the need for integrated, populationlevelpreventive strategies. Effective strategies across all levels of prevention are reviewed. Primordial and primary preventionstrategies include public health policies, health education to raise awareness, universal hepatitis B vaccination, expanded access toantiviral therapies for hepatitis B virus (HBV) and hepatitis C virus (HCV), lifestyle interventions targeting obesity and alcohol use,and environmental controls to reduce aflatoxin exposure. Secondary prevention focuses on early detection through viral hepatitisscreening and routine HCC surveillance in high-risk populations. Tertiary prevention aims to reduce morbidity and mortality throughtimely treatment and multidisciplinary care. Despite the availability of effective tools, substantial implementation gaps remainpersist. Underdiagnosis of viral hepatitis, low treatment uptake, inadequate surveillance coverage, and disparities in healthcareaccess continue to limit progress. Addressing these challenges requires a coordinated public health response grounded in healthsystem strengthening, policy innovation, and equitable access to care. A renewed public health commitment -integrating prevention,early diagnosis, and continuity of care- is essential to reduce the global burden of HCC and bridge the gap between knowledge andaction.

    더보기

    분석정보

    View

    상세정보조회

    0

    Usage

    원문다운로드

    0

    대출신청

    0

    복사신청

    0

    EDDS신청

    0

    동일 주제 내 활용도 TOP

    더보기

    주제

    연도별 연구동향

    연도별 활용동향

    연관논문

    연구자 네트워크맵

    공동연구자 (7)

    유사연구자 (20) 활용도상위20명

    이 자료와 함께 이용한 RISS 자료

    나만을 위한 추천자료

    해외이동버튼